AP Biosciences, Inc. (TPEX:6945)
Taiwan · Delayed Price · Currency is TWD 95.80
+0.50 (0.52%)
Sep 8, 2026, 1:30 PM CST
AP Biosciences Market Cap
AP Biosciences has a market cap or net worth of 9.29 billion as of September 8, 2026. Its market cap has decreased by -10.88% in one year.
Market Cap
9.29B
Enterprise Value
7.15B
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
95.80
ChartMarket Cap Chart
Since July 14, 2023, AP Biosciences's market cap has increased from 5.10B to 9.29B, an increase of 82.35%. That is a compound annual growth rate of 20.97%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 8, 2026 | 9.29B | -39.35% |
| Dec 31, 2025 | 15.32B | 262.77% |
| Dec 31, 2024 | 4.22B | 39.97% |
| Dec 29, 2023 | 3.02B | -40.79% |
| Jul 14, 2023 | 5.10B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Lumosa Therapeutics | 13.35B |
| ACRO Biomedical | 12.43B |
| TCM Biotech International | 10.00B |
| Polaris Group | 8.90B |
| Tanvex BioPharma | 8.40B |
| PharmaEngine | 8.30B |
| Locus Cell | 8.09B |
| TWi Biotechnology | 7.79B |